-
Mashup Score: 23Commencement of Atorvastatin and Ezetimibe Immediately in Patients Presenting with Acute Coronary Syndrome - 5 month(s) ago
Lipids are implicated in the development of coronary atherosclerosis. Achieving a significant reduction in lipid levels remains a crucial aspect of secondary prevention following an acute
Source: www.ecrjournal.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 131New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease - 12 month(s) ago
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an
Source: www.ecrjournal.comCategories: General Medicine News, Hem/OncsTweet-
La DISLIPIDEMIA ATEROGÉNICA y la TRÍADA LIPÍDICA se caracterizan por: 🔴Niveles elevados de triglicéridos 🟠Niveles bajos de HDL 🟡Niveles normales o elevados de colesterol LDL Eur Cardiol 2020; DOI: https://t.co/j88hhIK6AH
-
-
Mashup Score: 2Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review - 12 month(s) ago
For patients experiencing acute coronary syndrome, early symptom recognition is paramount; this is challenging without chest pain presentation. The aims of this scoping review were to
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Symptoms, Outcomes, Risk Factors of Atypical ACS: a Scoping Review" 📚 Just Published! 🔓Access it here 👉 https://t.co/yTDfaMCwV4 https://t.co/L6BdgcHSSa
-
-
Mashup Score: 0What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation? - 12 month(s) ago
Factor XIa (FXIa) may be involved in thrombus formation, but only to a lesser extent involved in haemostasis. Several novel FXIa inhibitors are under investigation, and Phase II trials
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Factor XIa Inhibitors’ Future Position in AF" 📚 Just Published! 🔓Access it here 👉 https://t.co/3eurOL7HvB #Anticoagulation #MedEd https://t.co/nPaRebij0S
-
-
Mashup Score: 0
Find out more about antiplatelet treatment with dual pathway inhibition in this free article from ECR Journal. Antiplatelet Treatment with Dual Pathway Inhibition.
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Antiplatelet Treatment with Dual Pathway Inhibition" 📚 Just Published! 🔓Access it here 👉 https://t.co/ziHNbCPG54 #Anticoagulation #MedEd #CardioEd https://t.co/KLxWm2nGOh
-
-
Mashup Score: 16European Cardiology Review (ECR) | ECR Journal | Radcliffe Cardiology - 12 month(s) ago
Cardiology consultants can find the latest news & information about cardiovascular disease & cardiology conferences by going to Radcliffe cardiology’s website.
Source: www.ecrjournal.comCategories: General Medicine News, Cardiologists1Tweet-
Proud of the European Cardiology Review Journal …an ever increasing impact factor now 3.2 Well done ! @jckaski and team https://t.co/QEBYBuTbiJ @radcliffeCARDIO
-
-
Mashup Score: 3
Resistant hypertension (RH) is defined as systolic blood pressure (SBP) or diastolic blood pressure (DBP) that remains ≥140 mmHg or ≥90 mmHg, respectively, despite an appropriate lifestyle
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Resistant Hypertension: An Overview" 📚 Just Published! 🔓Access it here 👉 https://t.co/f5OmZpsCnE #MedEd #CardioEd https://t.co/P7gDReMvJY
-
-
Mashup Score: 0Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach - 1 year(s) ago
The terms non-alcoholic fatty liver disease and non-alcoholic steatohepatitis have some limitations as they use exclusionary confounder terms and the use of potentially stigmatising
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Treatment Options and Continuity of Care in MAFLD" 📚 Just Published! 🔓Access it here 👉 https://t.co/RWSkYxY145 #MedEd #CardioEd https://t.co/kVyZGysj7a
-
-
Mashup Score: 0Assessment of the Ischaemic Effects of Myocardial Bridge by Echocardiographic Exercise Stress Test - 1 year(s) ago
Background: Detection of myocardial bridge (MB) at angiography suggests it has a role in ischaemic-related symptoms in patients with angina without obstructive coronary artery
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Echo-stress in Myocardial Bridge" 📚 Just Published! 🔓Access it here 👉 https://t.co/ncbt0SsRMp #MedEd #CardioEd https://t.co/7UhmH7r4QJ
-
-
Mashup Score: 0
Background: AF is a global health concern, with systemic complications including renal dysfunction. This systematic review and meta-analysis compares the effects of rivaroxaban, a Factor
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article: "Renal Impact: Rivaroxaban Versus Vitamin K Antagonists in AF" 📚 Just Published! 🔓Access it here 👉 https://t.co/xYoVYhTzng #Anticoagulation #MedEd #Electrophysiology #Arrhythmia https://t.co/oXyxAw6uEh
-
There is clear evidence that commencing CAD patients on combinations of therapies to lower LDL cholesterol makes enormous sense Read these articles and see why ! https://t.co/Kyxy7eNfZ6 https://t.co/d1WimoNlqK https://t.co/eWiTkNjWxt